Human immunodeficiency virus (HIV) seroprevalence among pregnant women
varies between and within countries and is generally higher in urban
than in rural areas. In the European Collaborative Study, heterosexual
transmission is increasing and most women are asymptomatic, although
the overall mean CD4 count is declining over time. There seems to be l
ittle evidence of an increased risk of pregnancy or delivery complicat
ions in HIV-infected pregnancies. Most studies have found no increase
in adverse pregnancy outcomes, although further research is needed. Pr
ospective studies suggest that pregnancy does not promote accelerated
disease progression in asymptomatic women. Despite earlier concerns, t
hree recent studies suggest that pregnancy is not associated with dete
rioration of immunocompetence. The increasing number of infected pregn
ant women requires adequate planning for the future care of their chil
dren.